Nestle has declined to comment on a report claiming it could sell US$1bn of assets in Latin America in order to secure final regulatory approvals for its Pfizer nutrition unit acquisition. Nestle is looking to sell the assets to ...
Tags: Nestle, sale report, nutrition acquisition, nutrition
Swiss food company Nestlé's $11.85bn deal to acquire Pfizer's infant nutrition business has received approval from the Chinese Ministry of Commerce, a move which brings the company closer to completing the acquisition. ...
Tags: infant nutrition business, anti-trust bodies, baby food market
The Competition Commission of India (CCI) has approved Nestlé's proposed acquisition of Pfizer Nutrition business. CCI said that considering the instance that Pfizer is not involved in the Indian nutrition marketplace, it is not ...
Tags: acquisition, nutrition marketplace, business of nutrition
Nestlé has completed the $11.85bn acquisition of Pfizer Nutrition, following the conclusion of the regulatory process in most markets. Pfizer Nutrition complements Nestlé's existing portfolio with brands in key segments and ...
Tags: Nestlé, acquisition, Pfizer Nutrition, infant cereal
Swiss food firm Nestlé has announced that it has completed the acquisition of Pfizer's nutrition division, in a deal valued at $11.85bn, strengthening its position in the global nutrition market. The integration process of Pfizer ...
Tags: Nestlé, food, acquisition, infant nutrition
The Australian Competition and Consumer Commission will not oppose the proposed acquisition of Pfizer Nutrition,a global infant nutrition business,from Pfizer Inc by NestléS.A,after accepting a court-enforceable undertaking.See ...
The Australian Competition and Consumer Commission (ACCC) has announced that it would not oppose Nestlé's $11.85bn deal to acquire Pfizer's infant nutrition business. However, the commission asked Nestlé to license its brand ...
Tags: ACCC, Nestlé, acquire, infant nutrition